Clara C.
- Country
- Belgium
- Department
- Gatro-enterologie
Research Overview
- Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Duvakitug for Induction Therapy in Moderately to Severely Active Crohn's Disease
- Phase 3b, Randomized, Open‑Label, Active‑Controlled Trial Comparing Guselkumab Versus Risankizumab for Efficacy and Safety in Moderately to Severely Active Crohn’s Disease
- Prevention of postoperative endoscopic recurrence with endoscopy-driven versus systematic biological therapy: a randomized, multicentre, parallel group pragmatic non-inferiority trial in adult patients with Crohn’s disease undergoing an ileocolonic resection with ileocolonic anastomosis
Data & Insights
Has run more than one trial at 142 of 231 partner sites.
Specializations
Gastroenterology & Inflammatory Bowel Disease
This investigator specializes in the management of Crohn's disease, with particular emphasis on postoperative care and disease recurrence prevention strategies.
- Postoperative Disease Management
- Endoscopic Recurrence Assessment
- Biological Therapy Implementation
The investigator focuses on developing optimal therapeutic approaches following ileocolonic resection procedures.
Surgical Outcomes Research
Expert focus on post-surgical monitoring and therapeutic intervention timing in inflammatory bowel disease patients.
- Surgical Recovery Protocols
- Risk Factor Assessment
- Treatment Timing Optimization
The investigator evaluates various therapeutic strategies for managing postoperative disease recurrence.
Therapeutic Innovation
Specialized interest in biological therapy applications and treatment escalation protocols for inflammatory bowel disease management.
- Targeted Biological Interventions
- Treatment Escalation Strategies
- Long-term Disease Control
The investigator studies comparative effectiveness of different therapeutic approaches in preventing disease recurrence.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.